Company profile
ALX Oncology
ALX Oncology is a clinical-stage biotechnology company advancing cancer therapies by boosting the immune system.
- Industry
- Biotechnology Research
- Employees
- 66
- Headquarters
- South San Francisco, California
- Founded
- 2015
- LinkedIn followers
- 7,422
- Office locations
- 1
ALX Oncology company summary
ALX Oncology is a company in the Biotechnology Research industry, headquartered in South San Francisco, California, founded in 2015. On LinkedIn the company has around 66 employees and 7,422 followers. Its listed specialties include Immuno-Oncology, Novel Biologics, Research and Development, Innovation, CD47.
What technology does ALX Oncology use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ALX Oncology
ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications.
Specialties
Where is ALX Oncology located?
ALX Oncology lists 1 location.
Compare companies similar to ALX Oncology
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ALX Oncology alxoncology.com | Biotechnology Research | 66 | 2015 | South San Francisco, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ALX Oncology
What does ALX Oncology do?
ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications.
How many employees does ALX Oncology have?
ALX Oncology has around 66 employees on LinkedIn.
Where is ALX Oncology headquartered?
ALX Oncology is headquartered in South San Francisco, California.
When was ALX Oncology founded?
ALX Oncology was founded in 2015.
Build a lead list from companies like ALX Oncology
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.